Atlas Trials

BETAmethasone Dose Reduction: Non-Inferiority on the Neurocognitive Outcomes of Children Born Before 32 Weeks of Gestation

Clinical trial NCT04021485 · RECRUITING

Trial details

NCT number
NCT04021485
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Premature Childbirth
Start date
2022-03-23
Primary completion
2025-10-31
Enrollment
643

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.